Literature DB >> 28615288

Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover.

Alyscia Cory Severance1, Philip J Sandoval1, Stephen H Wright2.   

Abstract

Organic cation (OC) transporter 2 (OCT2) mediates the first step in the renal secretion of many cationic drugs: basolateral uptake from blood into proximal tubule cells. The impact of this process on the pharmacokinetics of drug clearance as estimated using a physiologically-based pharmacokinetic approach relies on an accurate understanding of the kinetics of transport because the ratio of the maximal rate of transport to the Michaelis constant (i.e., Jmax/ Kt) provides an estimate of the intrinsic clearance (Clint) used in in vitro-in vivo extrapolation of experimentally determined transport data. Although the multispecificity of renal OC secretion, including that of the OCT2 transporter, is widely acknowledged, the possible relationship between relative affinity of the transporter for its diverse substrates and the maximal rates of their transport has received little attention. In this study, we determined the Jmax and apparent Michaelis constant (Ktapp) values for six structurally distinct OCT2 substrates and found a strong correlation between Jmax and Ktapp; high-affinity substrates [Ktapp values <50 µM, including 1-methyl-4-phenylpyridinium, or 1-methyl-4-phenylpyridinium (MPP), and cimetidine] displayed systematically lower Jmax values (<50 pmol cm-2 min-1) than did low-affinity substrates (Ktapp >200 µM, including choline and metformin). Similarly, preloading OCT2-expressing cells with low-affinity substrates resulted in systematically larger trans-stimulated rates of MPP uptake than did preloading with high-affinity substrates. The data are quantitatively consistent with the hypothesis that dissociation of bound substrate from the transporter is rate limiting in establishing maximal rates of OCT2-mediated transport. This systematic relationship may provide a means to estimate Clint for drugs for which transport data are lacking.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28615288      PMCID: PMC5539587          DOI: 10.1124/jpet.117.242552

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  41 in total

1.  Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.

Authors:  S Kapur; P Seeman
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

2.  PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates.

Authors:  Alex Avdeef; Per E Nielsen; Oksana Tsinman
Journal:  Eur J Pharm Sci       Date:  2004-08       Impact factor: 4.384

Review 3.  Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.

Authors:  Hideyuki Motohashi; Ken-ichi Inui
Journal:  AAPS J       Date:  2013-02-22       Impact factor: 4.009

4.  Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.

Authors:  J W Bloom; M Halonen; L J Lawrence; E Rould; N A Seaver; H I Yamamura
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

5.  Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.

Authors:  P Arndt; C Volk; V Gorboulev; T Budiman; C Popp; I Ulzheimer-Teuber; A Akhoundova; S Koppatz; E Bamberg; G Nagel; H Koepsell
Journal:  Am J Physiol Renal Physiol       Date:  2001-09

6.  Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat.

Authors:  T Budiman; E Bamberg; H Koepsell; G Nagel
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

Review 7.  Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.

Authors:  Anne T Nies; Hermann Koepsell; Katja Damme; Matthias Schwab
Journal:  Handb Exp Pharmacol       Date:  2011

8.  High-affinity phlorizin binding in Mytilus gill.

Authors:  S H Wright; A M Pajor; D A Moon; T M Wunz
Journal:  Biochim Biophys Acta       Date:  1992-01-31

9.  Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.

Authors:  Wing-Kee Lee; Markus Reichold; Bayram Edemir; Giuliano Ciarimboli; Richard Warth; Hermann Koepsell; Frank Thévenod
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-08

10.  pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.

Authors:  Sibylle Neuhoff; Anna-Lena Ungell; Ismael Zamora; Per Artursson
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

View more
  13 in total

1.  Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.

Authors:  Philip J Sandoval; Kimberley M Zorn; Alex M Clark; Sean Ekins; Stephen H Wright
Journal:  Mol Pharmacol       Date:  2018-06-08       Impact factor: 4.436

Review 2.  Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.

Authors:  Avner Schlessinger; Matthew A Welch; Herman van Vlijmen; Ken Korzekwa; Peter W Swaan; Pär Matsson
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

3.  Novel method for kinetic analysis applied to transport by the uniporter OCT2.

Authors:  Stephen H Wright; Timothy W Secomb
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-21

4.  Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier.

Authors:  Raymond K Hau; Joseph S Tash; Gunda I Georg; Stephen H Wright; Nathan J Cherrington
Journal:  J Pharmacol Exp Ther       Date:  2022-07-02       Impact factor: 4.402

5.  Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.

Authors:  Siennah R Miller; Raymond K Hau; Joseph L Jilek; Mark N Morales; Stephen H Wright; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2020-05-11       Impact factor: 3.922

6.  A proton-coupled folate transporter mutation causing hereditary folate malabsorption locks the protein in an inward-open conformation.

Authors:  He-Qin Zhan; Mitra Najmi; Kai Lin; Srinivas Aluri; Andras Fiser; I David Goldman; Rongbao Zhao
Journal:  J Biol Chem       Date:  2020-09-06       Impact factor: 5.157

Review 7.  Role of SLC transporters in toxicity induced by anticancer drugs.

Authors:  Kevin M Huang; Muhammad Erfan Uddin; Duncan DiGiacomo; Maryam B Lustberg; Shuiying Hu; Alex Sparreboom
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-04-26       Impact factor: 4.481

Review 8.  Molecular and cellular physiology of organic cation transporter 2.

Authors:  Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2019-11-04

9.  Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.

Authors:  Philip J Sandoval; Mark Morales; Timothy W Secomb; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-17

10.  Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine.

Authors:  Robert Elsby; Stephen Chidlaw; Samuel Outteridge; Sarah Pickering; Amy Radcliffe; Rebecca Sullivan; Hayley Jones; Philip Butler
Journal:  Pharmacol Res Perspect       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.